Clinically meaningful benefits with GLP-1RA in patients with HFpEF and obesity3' education - Oct. 9, 2023 - Mikhail Kosiborod, MD - Kansas City, MO, USA
This video was recorded during the ESC Congress 2023 in Amsterdam, The Netherlands
Mikhail Kosiborod, MD is a Cardiologist and Vice President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City.
This recording was developed under auspices of EPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of EPCCS.